-
Buyout
Envision Pharma
United-KIngdom
Healthcare & life scienceExited
Healthcare & life scienceEnvision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies. Envision currently has ten offices, three in the United Kingdom, five in the United States, two in Asia Pacific, and employs around 450 team members.
-
Buyout
Trigo
France
Business servicesBusiness servicesFounded in 1997, TRIGO is a multinational company providing quality management solutions for the manufacturing sector, particularly within the transportation industries. With annual revenues of +300 M€ and a team of more than 9,000 professionals present in 20 countries, TRIGO offers a comprehensive portfolio of Quality Management and Inspection Services to the leading international manufacturers of the automotive, aerospace and heavy transportation industries.
Deal team
Press releases
- Trigo, supported by Ardian, acquires French specialist Euro-Symbiose
- Francis Niss appointed as new chairman of the supervisory board of Trigo
- Trigo to join forces with Böllinger in Germany with Ardian's support
- Ardian enters into exclusive negotiations to acquire Trigo Group from IK investments partners
-
Co-Investment
Mirion
USA
Healthcare & life scienceExited
Healthcare & life scienceMirion-Canberra group is a global provider of radiation detection, measurement, analysis and monitoring products to the nuclear, home security & defence, and medical markets. The group derives most of its revenues from segments where it holds global #1 market positions: radiation monitoring systems, radiochemistry and health physics. It operates 18 industrial sites and employs ~ 2,000 people.
-
Infrastructure
Lyrestad Holding AB
Sweden
RenewablesRenewablesLyrestad Holding AB consists of wind farms in Sweden providing a total capacity of 75,9MW.
A 10-year PPA has been signed with Google enabling the full off-take of power at a fixed price of 35.5€/MWh.Deal team
-
Co-Investment
Seqens
France
IndustrialsIndustrialsSeqens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.
-
Co-Investment
MultiPlan
USA
Healthcare & life scienceHealthcare & life scienceMultiPlan is the industry’s most comprehensive provider of healthcare cost management solutions in the U.S. With a network of over one million healthcare providers with extensive proprietary analytics, Multiplan generates over $11 billion in medial cost savings on about 40 million claims annually, acting as an intermediary on behalf of those paying for healthcare. In exchange, healthcare providers benefit from directed patient flow and a single point of payment.